Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAGOYA-HEART Study
NCT00129233Phase 4Completed
- Sponsor
- Nagoya University
- Start
- Oct 2004
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valsartan, amlodipine in hypertension (HTN), type 2 diabetes mellitus (T2DM), sponsored by Nagoya University. Started Oct 2004; status: completed.
02
Drugs
valsartanamlodipine
03
Conditions
hypertension (HTN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00129233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00129233.